Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA rash on your arms while taking Mounjaro is worth paying attention to, but it doesn't always mean you need to stop treatment. Most arm rashes reported on tirzepatide fall into one of three categories: a local reaction at the injection site, a wider skin reaction linked to the medicine, or something unrelated that happens to coincide with starting. Understanding which one you're dealing with shapes every decision that follows. Mounjaro (tirzepatide) is a prescription-only medicine, and any new or persistent skin change should be discussed with your prescriber rather than managed alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The arm is one of three licensed injection sites for Mounjaro, alongside the abdomen and thigh. When a rash appears on your arm and you inject there, the first question is whether the skin change is sitting right over (or very close to) the injection point itself.
Localised injection-site reactions are recognised in the Mounjaro prescribing information and tend to look like a small red patch, a raised welt, or mild swelling that fades over a day or so. They're more common when the pen is injected into the same spot repeatedly. Rotating your site each week (moving a few centimetres from last week's point, or switching to the abdomen or thigh for a couple of doses) often reduces them. Letting the pen reach room temperature before injecting, and not rubbing the skin straight after, can also help.
If the redness stays confined to that small area and resolves within 48 hours, it's generally consistent with a normal local response. That said, "normal" doesn't mean you should ignore it: tell your prescriber at your next review, and note which site and which dose it followed. Patterns matter. You can read a broader look at how Mounjaro and skin reactions interact on our guide to Mounjaro rash, which covers both site-specific and systemic presentations.
A rash that creeps outward from the injection site, crops up symmetrically on both arms, or appears on areas you haven't injected is a different picture. This pattern suggests the immune system is responding to tirzepatide itself rather than to the needle puncture, a systemic skin reaction rather than a local one.
According to the NHS medicines information for tirzepatide, skin reactions including rash, itching and hives are listed side effects that should be reported to a healthcare professional. A widespread rash, particularly one accompanied by joint pain, fever, or swollen glands, could also point to a serum-sickness-type reaction, which is rarer but needs proper assessment.
Timing is a useful clue. If the rash appears within hours of your weekly injection and fades before the next dose, that's a different pattern from one that builds steadily across the four-week pen. The dose level matters too: reactions sometimes surface only when the dose steps up, then settle again. Keep a simple note, date of injection, which site, when the rash appeared, what it looked like, and whether it was itchy or painful. That log is genuinely useful when your prescriber reviews your case, and our dedicated page on rash from Mounjaro explains what to record and why those details help your prescriber reach the right conclusions. There's more detail on this presentation in our overview of Mounjaro skin rash patterns.
Starting a new medicine is a natural moment to notice things about your body that were already there. Heat rash, contact dermatitis from a laundry product or fabric, an unrelated viral infection, or a reaction to sun exposure can all produce arm rashes that have nothing to do with tirzepatide. This doesn't mean dismissing the possibility of a drug reaction, it means gathering the full picture before drawing conclusions.
Ask yourself a few practical questions. Did you change detergent or moisturiser recently? Is the weather unusually warm? Do people around you have similar symptoms? Has a similar rash appeared before, even years ago? If the rash appeared on non-injected skin and you'd also notice it if you weren't taking Mounjaro, a GP can help tease apart the cause.
One thing worth being aware of: if you're planning any surgical procedure, your clinical team and anaesthetist need to know you're taking tirzepatide. That's a general rule, and it applies to any dermatology procedure or biopsy too, including any work on skin affected by the rash itself.
For context on the broader effects of tirzepatide beyond skin reactions, see our page on what Mounjaro does in the body. And if you're still in the early stages of deciding whether this treatment is right for you, our weight-loss treatment overview sets out the full picture. Those who are mid-treatment and wondering about cost (for instance, if a pause in treatment is raising questions about whether to continue) can find context on Mounjaro pricing in the UK.
Most arm rashes on Mounjaro don't require emergency action, but a few signals should prompt you to seek help the same day, regardless of whether it's a Tuesday afternoon or the day before a bank holiday.
Get urgent help (call 999 or go to A&E) if any rash is accompanied by swelling of the lips, tongue, or throat, difficulty swallowing or breathing, a rapid heartbeat, or feeling faint. These could indicate anaphylaxis, a rare but serious allergic reaction. Do not take your next dose until you've spoken to a doctor.
Contact your prescriber promptly (within 24 to 48 hours) if the rash is spreading, is significantly painful rather than just itchy, has blistered, or has been present for more than a week without improving. The same applies if you develop a rash at a dose level you've previously tolerated well, as that change of pattern is clinically meaningful.
For reactions that are mild, confined, and improving, report them at your next scheduled review and log them in the meantime. The Yellow Card scheme at the MHRA is also open to patients directly, you don't need a clinician to submit a report on your behalf, and doing so helps build the national picture of how tirzepatide behaves in real-world use. You can read more about rash reactions across different sites in our guide to tirzepatide skin reactions.
If you'd like to discuss a skin reaction with a prescriber before your next scheduled review, or if you're considering starting Mounjaro and want your medical history assessed properly, our team is available seven days a week. Start your free consultation and a GPhC-registered prescriber will review your case.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.